Regional cerebral blood volume (CBV) can be calculated using data obtained during the kinetic analysis of 18F-labeled 2-fluoro-2-deoxY-D-glucose (FDG) uptake measured by positron emission tomography (PET). As a result the influence of vascular activity upon the determi nation of FDG rate constants can be minimized. The method is investigated by simulation experiments and by analysis of PET studies on seven older, healthy human volunteers aged 52-70 years. The accuracy of measured FDG rate constants kl' k2, and k3' obtained either by omitting the early portion of the uptake curve or by ex plicit inclusion of CBV as a fit parameter, is compared. The root mean square error in measured rate constant for the latter method is equivalent to that obtained by omit ting the first 2. 5-3 min of tissue data and neglecting the CBV term. Hence, added information about the physio logical state of the tissue is obtained without compro-
The use of 18 F-labeled 2-f1uoro-2-deoxY-D-glu cose (FDG) and positron emission tomography (PET) to determine regional cerebral glucose was introduced in humans by Reivich et al. (1979) , using the deoxyglucose model of Sokoloff et al. (1977) , and extended to include phosphatase activity by Phelps et al. (1979a) . Since then the method has been used to study a variety of pathological condi tions (Phelps et aI. , 1982; Yamamoto et aI. , 1984) . The method estimates regional glucose utilization by comparing the observed tissue activity concen-mising the accuracy of the (FDG) rate constant measure ment. In hyperemic tissue the explicit determination of the vascular fraction results in more accurate estimates of the FDG rate constants. The ratio of CBV determined by this method to CBV obtained using CISO in six sub jects with CBV in the normal range was 0.92 ::!: 0.32. A comparison of the CBV image obtained by this method with that obtained using CISO in an arteriovenous malfor mation case demonstrates the accuracy of the approach over a wide range of CBV values. The mean value for CBV fraction in gray matter obtained by this method in the older control group was 0.040 ::!: 0.014. Average gray matter rate constants obtained were kl = 0.084 ::!: 0.012, k2 = 0.150 ::!: 0.071, and k3 = 0.099 ::!: 0.045 min-I. Key Words: Cerebral blood volume correction-2-Fluoro-2-deoxY-D-glucose-Positron emission tomography -Rate constants.
tration in a single scan with that expected if the rate constants for the transport and metabolism of FDG are assumed to be equal to some population average. By also assuming that the ratio of glucose utilization to FDG utilization is fixed, a linear transformation for converting observed tissue 18F concentration to units of glucose utilization is ob tained. For a broad range of utilization rates, the value obtained from this approach is relatively in sensitive to differences between the true rate con stants in the tissue and their assumed values. In some pathologies, particularly in hypometabolic areas, significant errors can occur (Hawkins et aI. , 1981) . Alternative formulations have been intro duced to minimize the impact of the difference be tween the rate constants for the case being studied and their assumed values (Brooks, 1982; Hutchins et aI., 1984) . Increasing emphasis is being placed upon the direct determination of the rate constants, both to improve the accuracy of the operational equation and to allow a characterization of brain pathology in terms of the underlying kinetics of blood-brain barrier transport and hexokinase-me diated phosphorylation of glucose (Friedland et al. , 1983; Wienhard et aI. , 1983 Wienhard et aI. , , 1985 Heiss et aI. , 1984; Gjedde et aI. , 1985; Reivich et a!. , 1985) .
The determination of the FDG rate constants is usually performed by nonlinear fitting of the tissue uptake curves, obtained from a series of rapid se quential PET scans following FDG injection. The method has the inherent problem that the region of interest used to define the tissue activity curve con tains activity from the vascular space. The fraction of radioactivity in the region of interest that is con tributed by the vascular compartment is large in the first few minutes. Failure to account for this contri bution may lead to erroneous estimates of the FDG rate constants. Kato et al. (1984) proposed a method in which the vascular fraction could be in cluded as a fitting parameter if the plasma activity were held constant. This method requires the prior determination of the plasma response to a rapid bolus injection to calculate the infusion schedule that will yield a constant plasma level (Patlak and Pettigrew, 1976) .
The present article describes an alternative ap proach to CBY and rate constant measurement, which provides the same information but does not re quire the time-consuming and error-prone pre paratory procedures before infusion. A prolonged bolus injection and rapid plasma sampling allow the plasma curve to be sufficiently well sampled for the CBY component to be extracted from the early part of the observed tissue curve. Recently, Hawkins et al. (1986) described a similar strategy for incorpo rating CBY as a model parameter in the FDG method. In that work the authors addressed the problem of sharp changes in the tissue curve during the early scans following a bolus injection by inte grating the model curve over each scan. In the present work potential errors are minimized by a combination of shorter scans, extended infusion, and a recursive time adjustment during fitting. Using simulated plasma and tissue curves, the in clusion of CBY as a model parameter is investi gated and compared with the model having no vas cular component in the observed tissue curve. The effects of a number of conditions encountered with real data are modeled in both cases. In addition to the error analysis, the PET scan data from a set of older normal volunteers are analyzed both ways. The results are compared both with each other and with the simulated data.
THEORY
The operational equation (Sokoloff et aI., 1977; Phelps et aI. , 1979a) calculates the glucose utilization rate by comparing the observed tissue activity in a single scan with that expected using assumed values for the rate con stants of the FDG compartmental model. The equation can be expressed simply as follows, with bars indicating normal values:
where LCMRglu is the local CMRglu expressed as
Cgf

LCMRglu = LC
(2)
Where f is the fractional FDG phosphorylation rate under steady-state conditions expressed as
and LC is the lumped constant (the ratio of the utilization rates for deoxyglucose and glucose under steady-state conditions).
C/T) is the observed tissue activity concentration at time T expressed as
Ce(T) is the calculated activity concentration in the pre cursor pool expressed as
Cm(T) is the calculated activity concentration in the me tabolized pool expressed as
Cp(t) is the arterial plasma concentration of FDG at time t; Cg is the plasma glucose concentration; k l ' kz , k3 ' and k4 are the rate constants for forward and reverse FDG trans port, FDG phosphorylation, and FDG-6-phosphate de phosphorylation, respectively and 1 a 2
The expression Cj(T) -Ce(T) is an estimate of Cm(T), and glucose utilization is implicitly assumed to be propor tional to the Cm(T)ICm(T) ratio. The observed tissue curve is represented by the equation
(3) Kato et al. (1984) defined the observed uptake curve to include the vascular contribution explicitly as
where A;(T) is the volume-weighted average of the tissue and vascular activity concentrations at time T and CBV is expressed as the fraction of vascular space in the unit volume of brain tissue. By fitting the observed FDG tissue curve with Eqs. 3 and 4, the value of CBV can be explicitly determined on a regional basis and the int1u ence of CBV upon the measured rate constants mini mized.
Effect of heterogeneity in vascular compartment
For the analysis of PET data, a modification is required to account for differences between plasma and whole blood activity concentrations. Equation 4 assumes that the activity concentrations in plasma Cp(T), in red blood cells Cr(T), and in whole blood Cb(T) are equivalent and that eb(T) can be replaced by Cp(T). Phelps et al. (l979a) have shown that the ratio Cr(T)ICp(T) increases from �0.80 to 0.88 over the 40 min after injection. To include this information. the activity in the cerebral vascular compartment, equal to Cb(T) . CBV. is given by
where Vp and Vr are plasma and red cell volumes. respec tively, and Vp + Vr = CBV.
Using the large-vessel hematocrit H and a cerebral he matocrit correction factor of 0.69 (Lammertsma et al. . 1984) , and defining beT) = C(T)ICp(T). we have
Setting beT) to the linear mean value of 0.84 over 40 min and taking H as 0.39 (Phelps et al. . 1979a) give a mean a of 0.957. Hence, there is a 4-5% systematic un derestimation of CBV from fitting the observed tissue up take curve with Eq. 4 and assuming Cp(T) to be equal to Cb(T). Dividing the apparent CBV by a effectively re duces this error to a negligible level. This adjustment does not take account of differences between pre-and postcapillary intravascular activity (Koeppe et aI. , 1985) . Such second-order refinements were considered inappro priate for a model in which the accurate determination of FDG rate constants is the principal objective.
METHODS
Simulation
To simulate the input function Cp(T) from an extended infusion schedule. the input function from a typical bolus injection was first fitted with a sum of five time-weighted exponentials of the form tA· exp( -at). and then this ana lytic form was convolved with a square-pulse function of fixed duration. The resultant input function was scaled to maintain the same area under the plasma curve in each case, a procedure equivalent to maintaining constant dose. The pulse functions chosen corresponded to con stant infusions with duration of 10,30.60. 120, and 300 s. A tissue curve AlT) was then generated by evaluating Eq. 4 at each of a set of specified sampling points. When generating the Cj(T) curve, the effect of k4 was explicitly included using the formalism of Phelps et al. (l979a) . Samples were generated every 30 s from 0 to 3 min, every minute from 3 to 6 min, every 2 min from 6 to 12 min. and every 5 min from 15 min on. The early portion of the input function and its corresponding tissue curve are shown in Fig Step widths of 0-300 s are shown. B: Each input function from A was combined with specified rate con stant and cerebral blood volume values to obtain the sam pled tissue curves shown. Rate constants were taken for gray matter from Huang et al. (1980) . signed to the rate constants were those for gray matter from Huang et al. (1980) of kl = 0.102 min-I, k2 = 0.130 min -1, k3 = 0.062 min -1. and k4 = 0.0068 min -1; while the CBV fraction was set to 0.04. Unless otherwise stated all fitting was performed from 0 to 40 min after the start of infusion. The tissue curve was then fitted by a nonlinear optimi zation routine to determine the apparent values of k 1 • k2, k3, and CBV using the algorithm of Marquardt (1963) ,
This method employs a gradient search to identify the global minimum, followed by an analytic solution devel oped from linearizing the fitting function in the vicinity of that minimum. Derivatives of Eq. 4 with respect to the four variables were determined using numerical integra tion of the plasma curve, since exponential models cannot represent the extended infusion input functions. Optimization was performed with different constraints to evaluate their effect upon the results; for instance, the effect of ignoring or fixing the CBV parameter instead of explicitly determining its value during optimization was studied.
Although k4 was not optimized in the fitting procedure, its effect was explicitly included in the calculation of tissue activities during fitting by assuming a value of 0.0068 min -1. When fitting real tissue data, this approach reduces the k4-related error to that due to differences be tween the assumed and the actual value of k4• Similarly, in some runs CBV was not optimized but its effect was included by using a prespecified value while optimizing only kb k2, and k3. This allowed for the simulation of the method in which CBV is either neglected or its value taken from a separate PET study.
Effect offinite scan time. In this simulation work, the tissue activity curves were generated by calculating the instantaneous tissue activity Ai at the midpoint of the scan tm' As has been pointed out by Hawkins et a!. (1986) , the tissue concentration measured by PET repre sents the integral of the continuous tissue function over a finite period; this average activity will differ somewhat from the instantaneous value of Ai at tm' The discrepancy is most pronounced for longer (>60 s) scans during the first few minutes of a dynamic study when considerable vascular activity produces a sharp peak in the continuous Ai curve. This may lead to significant errors in the esti mation of rate constants k ] and k 2 and of CBY. Hawkins et a!. (1986) developed a modified formula for the observed tissue counts, which explicitly integrates the continuous model function between scan limits during the optimiza tion procedure. In this work an alternative procedure is employed that allows the continued use of the tissue function from Eqs. 3 and 4. Since the average Aj value measured must equal the instantaneous value at some time in the scan ti, the procedure recursively adjusts the time of the measurement from tm toward tj for those early scans where these two times are likely to be significantly different. At each recursion the time at which the model tissue function equals its scan average is used as the new scan time. Typically two recursions are sufficient to con verge at the 1 % level. In addition, by extending the injec tion time and by keeping scan durations to <60 s, the nonlinearity of the tissue function within a single scan is reduced to the point where the simple model of Eqs. 3 and 4 is adequate. Ta ble 1 illustrates the effect of the above approaches for two CBV values and three scan pe riods. At a large CBV fraction of 0. 20, a 40% underesti mate in CBV fraction obtained with 2-min scans is re duced to 3% by adjusting tm toward ti. For 30-s scans the errors involved are negligible.
Noise model. Where appropriate, random noise was added to the tissue data to generate an ensemble of noisy 
FDG lIptake curve
Fit parameter
A 60-s infusion was used as the input fu nction, while the spec ified model parameters were k I = 0. 102 min-I , k2 = 0. 130 min -I, k3 = 0.062 min -I, and CBV fraction = 0.04 or 0.20. Numbers in parentheses illustrate the effect of adjusting the time point of these early scans from the scan midtime tm toward the instantaneous time tj (see text). Significant errors of 20-40% are found in longer (>60 s) scans unless the adjustment is made. For the 30-s early scans used in this work, the errors involved are negligible.
curves from a single noise-free curve. Noise was added to the Ai curve using a Poisson distribution of mean zero and standard deviation CTi given by
where Ni is the total counts in scan i of length dTj ex pressed as
Ni = AjdTi
Nm is the mean count per scan expressed as
This formulation allows the assignment of a mean noise level F to a given tissue curve, although the noise ampli tude added to any scan point within the curve is propor tional to the number of counts collected in that scan. Hence, rapid sampling schemes have better temporal resolution at the expense of a greater statistical penalty. Figure 2 shows a representative noise pattern at five noise levels superposed upon the bolus tissue curve.
To allow direct comparison of tissue curves from the same dose but different input schedules, the normaliza tion constant Nm from the bolus curve in normal tissue was used for all tissue curves. Hence, since a single scan from ischemic tissue would accumulate fewer counts Nj than an equivalent scan from normal tissue, the use of a fixed Nm implies a noisier curve in the ischemic case. The choice of noise level F then reflects the noise transport characteristics of the PET scanner. Typical 1.5-cm2 re gion-of-interest tissue curves from the MNI PET scanners, the Therascan 3128 (Cooke et a!. , 1984) and the Positome Hlp (Thompson et a!. , 1986) , exhibit mean noise levels in the 2-3% range, while single-pixel curves are better represented by the 6-10% range. Typically 7 -11 M image-forming counts are collected in a 40-min FDG dynamic study, giving an Nm of 300-450 K counts per scan.
For each tissue curve, nine noise patterns were added at each of five noise levels (2, 4, 6, 8, 10%). The noisy data were fitted to determine the apparent values for k], k2, k3, and CBV and the results compared with the true values using the root mean square (RMS) error at each noise level, where
where kj is the apparent value for rate constant (or CBV) from fit i. K is the true value for rate constant (or CBV). N is the number of noise patterns.
PET studies
FDG was prepared in the MNI Cyclotron Unit using a method that restricts contamination by 2-fluoro-2-deoxy D-mannose to �5% as measured by ] 9F nuclear magnetic resonance (Diksic and Jolly, 1986) . Radiochemical purity, measured by thin layer chromatography, was >96%. Spe cific activity, measured by high performance liquid chro matography, was �680 mCi/mmol. Simulation studies pattern added at different mean noise levels (see text). Ap parent oscillatory nature of the noise is spurious since the family of patterns showed no consistent structure. Note the increased relative noise for the shorter scans at early times and that even small mean noise levels will generate poorly determined points in this area.
performed to evaluate the effect of 5% 2-fluoro-2-deoxy D-mannose contamination showed a slight (�2'16) eleva tion in kj, k2, k3, CBV, and LCMR glu' Experimental results were obtained in a series of con trol studies performed on the Therascan 3128 positron to mograph (Cooke et aI. , 1984) . The determination of re gional CBV and FDG rate constants was performed in seven healthy, older volunteers, with a mean age of 63. 0 :± 6.0 years, who had fasted overnight before the study. Three of these subjects were also scanned with CI50 to obtain CBV maps. The data from these studies were compared with the CBV maps from the FDG studies. Further comparisons were possible using the FDG dy namic and CI50 data from three patients with Hun tington's disease, yielding six studies where CBV values were in the normal range. In addition, FDG kinetic data were analyzed for a 28-year-old patient with a large arte riovenous malformation in the left precentral area. The CBV map obtained from this study was compared with that obtained from a CI50 study to assess the quantitative capability of the FDG method in hyperemic tissue. In all studies ambient light and noise were subdued but no eye patches or earplugs were employed. A 5-mCi dose of FDG was injected intravenously as an extended bolus of typically 60-s duration. The infusion rate was kept ap proximately constant, although no special procedures were employed to obtain constancy. Plasma activity con centrations were sampled using an indwelling catheter in the radial artery. A series of 20 rapid sequential PET scans were obtained over a 45-min period for three ana tomical planes separated by 12 mm and centered 42 mm above the orbitomeatal reference line. Scan durations were 30 s for 0-3 min, I min for 3-14 min, 2 min for 14-20 min, and 5 min for 20-45 min. Although these scan durations differed from those of the simulations in the period from 6 to 20 min, the schemes were identical over the important early phase. Simulations indicate no signif icant systematic differences in fitted parameters from the two schedules.
Reconstruction was performed with software correc tion for detector efficiency variations, random events, No.6, 1986 and dead time as well as a deconvolution procedure for scattered events (Cooke and Evans, 1983; Cooke et aI. , 1984) similar to that of Bergstrom et al. (1983) . Attenua tion correction was performed using a projection thresh olding method similar to that of Bergstrom et al. (1982) , Owing to the limited number of counts available in the short scan periods. gantry wobble to increase sampling and provide higher-resolution images was not employed. Image resolution in this mode. measured as the full width at half-maximum of the line spread function, is 19 (trans verse) x 11 (axial) mm.
Two methods of image analysis were employed to gen erate tissue activity curves. To produce an image of the distribution of rate constants or CBV, the activity in a 3
x 3-pixel array about each pixel within the skull boundary was recorded as a function of time and the re sulting time-activity curve fitted with Eq. 4 holding k4 at a fixed value of 0.0068 min -I. This procedure takes 3 h/ slice on a VAX 11/750 system. For more routine applica tion a procedure for defining and storing irregular regions of interest was utilized. Regions were specified in each hemisphere for anterior/midfrontal, precentral, postcen tral, posteroparietal. and occipital cortex and for cau date/putamen and thalamus to yield 14 regions in total. These regions are illustrated in Fig. 3 . Owing to the low resolution nature of the dynamic scans. no attempt was made to define regions of interest for white matter. The mean region-of-interest activity concentration in each scan was used to generate the tissue curve to be fitted. The total fitting time was typically 1.5 min/slice. For each region the mean and coefficient of variation among sub jects were determined for each fitted parameter. where SD coefficient of variation = x 100% (10) mean In addition, the mean and coefficient-of-variation values for all regions in each patient were calculated.
The validity of the operational Eq. 1 in estimating LCMRglu is dependent upon the constancy of the lumped constant since any variation in this term is expressed proportionately in the apparent LCMRglu proposed the measurement of a stability fa ctor for the lumped constant defined in terms of the FDG rate constants as
This factor was calculated for all regions and the results analyzed by region and by subject.
RESULTS
Simulation
The effect of CBV on the apparent rate constants is shown in Fig. 4 , where fitting is initiated at 2, 4, or 6 min and CBV is held constant at a predefined value. For comparison the results when CBV is also optimized are included. In this case there is no sig nificant difference between the results obtained and the input values. When CBV is held constant, a curves generated with increasing cerebral blood volume (CBV) components and with no noise added. When CBV is fitted (5), the rate constants k1-k3 are correctly determined at 0.102, 0.130, and 0.062 min-l, respectively, for all CBV values. When a fixed value of CBV is assumed, 0.00 in A or 0.04 in B, and the first 2, 4, or 6 min of tissue data are ne glected, a linear distortion is introduced that is most pro nounced for k2• linear distortion is seen, most pronounced for k2 and minimal for k3. For a true CBV of 0.04, k2 is overestimated by 15% and k1 overestimated by 7% when the first 2 min of the tissue curve is not con sidered and CBV is assumed to be negligible. These errors are reduced to 7 and 3%, respectively, if the first 6 min is ignored. By assuming CBV to be 0.04 and fitting the CBV -adjusted curve, this distortion is reduced to <10% for k2 and to <5% for k1 over the CBV range of 0.02-0 .06. Since ignoring the early portion of the curve re moves potential information, particularly about k1' some loss of precision might be expected. Figure 5 illustrates the root mean square error for the ap parent results at different noise levels when fitting is initiated at 2, 4, or 6 min. k2 is seen to be most sensitive to noise, while the stability of the results is steadily degraded as more of the early portion is ignored. The four-parameter fit with CBV included is also shown and exhibits a stability fo r k1' k2' and k3 comparable with that obtained by the dropping of 2.5-3 min when CBV is not included as a free pa rameter in the fit. Figure 6 illustrates the effe ct of an incorrect mea sure of the plasma peak height upon the fitted pa rameters fo r a true CBV of 0.04. The plasma ac tivity measurements over the first 90 s after a typ ical bolus injection, paired as (time ; activity) in units of (s; counts/s/g), were (10;57), (20;9,3 17), (3 1;18,5 1 8), (44;10,939), (58;8,0 15), (72 ;6,702), (90;6,5 19). The two highest points on the measured plasma curve were multiplied by a scaling factor and the modified curve used in the fitting proce dure. Clearly CBV is particularly sensitive to this error, varying from 188 to 63% of the true value as the apparent peak height varies from 50 to 150% of the true value. To reduce the sampling constraints, the possibility of using a slow injection to broaden the initial plasma peak was investigated. Figures 7  and 8 show the root mean square error for each of the fitted parameters, at different levels of added noise, as the infusion time was varied from 0 s, i.e. the analytic form of the bolus plasma curve, up to 300 s. A minimum in the error plots is seen for k1 and k2 at between 1 and 2 min in both normal and ischemic states. For CBV there is a slight minimum at �20 s, while k3 shows a clear improvement up to 60 s and then a slight rise for the 2-4% noise level. The root mean square errors are considerably worse for k1' k2, and k3 in the ischemic model shown in Fig. 8 as compared with the normal model, since the tissue counts from the same dose are lower and all noise levels refer to the mean noise level in the fast bolus/normal model. For the highest noise levels and/or longer infusion Mean Noise Level (%)
schedules, reasonable convergence could not be obtained with the ischemic tissue curves. Figure 9 compares the effect of time displace ments of the plasma curve upon the four fitted pa rameters for a set of known CBV and rate constant values. Data for the rapid bolus injection and a 60-s infusion indicate that the bolus method is less sen sitive to timing errors. As before, kz is the least stable parameter and k3 is relatively insensitive to timing error. For k\, kz, and k3 the error in opti mized parameters is <5% for time shifts of < IO s 0.20 ,-------------, Fig. 1 B was fitted using a modified form of the original plasma curve where the highest two points were scaled by the factor shown as abscissa. CBV fraction is seen to vary from 0.075 to 0. 025 as the peak height is scaled by 50-150%, indicating the need to properly characterize the plasma cu rye.
J each Blood FlolI" Mefab , Vol. 6. No.6. 1986 Fig. 4 . Fitting the extra CBV parameter is seen to be equivalent to neglecting between 2.5 and 3 min of tissue data. Note that the mean noise level is defined differently from the root mean square error (see text).
and a CBV of 0.04 or less. At a CBV of 0. 10, the corresponding error limit is 19%. The corre sponding error curves for CBV at these two levels are included in Fig. 9C along with those for three other CBV levels. As the plasma curve is shifted backward in time, the tissue curve appears to rise more slowly, relative to the plasma curve, at early times and so a lower CBV estimate results.
PET studies Table 2 shows the mean value and coefficient of variation for the rate constants and CBV for the se lected regions. Owing to the large coefficient-of variation values for all parameters except k\, data from left and right hemispheres were pooled for each anatomic region. Further pooling of anterior, posterior, and basal ganglia data is also included. The rate constants obtained are compared with those from other studies in Table 4 . Table 3 shows the mean value and coefficient of variation for each patient, as well as a comparison of LCMRg\u determined directly from the individual rate constants with that determined using the rate constants of Huang et al. (1980) and the Brooks re formulation (1982) of the operational equation, a form that is less sensitive to differences between the true and the assumed rate constants than the original form. In both cases a lumped constant of 0. 42 was used (Phelps et aI. , 1979a) . The mean uti lization rates for gray matter in each subject range from 34. 1 to 54. 6 f.Lmol/IOO g/min for the direct cal- .10 �---�--- culation using Eq . 2 and fr om 26.7 to 48 .9 f-lmol/IOO g/min using the operational Eq . 1. To study the im pact on the rate constants of including the CBV pa rameter during fitting, the data were reanalyzed with CBV assumed to be zero and with data points earlier than 4 min after injection excluded. Ta bles 2
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Infusion Duration (sec) and 3 shows the corresponding results by regIOn and by subject. If only the cortical regions are considered, the changes observed were + 8.4% for k], + 17.4% for k2, and -6 .5% for k3; for comparison the simula tion results of error for fitted parameters as a function of infusion time using ischemic rate constants for gray matter of Hawkins et al. (1981) : k, = 0.033 min-' , k2 = 0.180 min-' , k = 0.053 min-' , k4 = 0.0084 min-' . Note that the normalization constant Nm was the same as for Fig. 7 . Hence, the lower tissue ac tivity in the ischemic model yields noisier curves and higher root mean square errors than the normal model for a given mean noise level. + 15, and -3.5%, respectively, for these param eters at a CBY of 0.04 and when omitting the first 4 min of tissue data from analysis. The lower coeffi cient-of-variation values obtained for k" k2' and k3 when fitting CBY also show general agreement with the simulation results of Fig. 5 . The comparison of CBY determined by C'50 or FDG in three older controls and three Huntington's disease patients yielded a CBY FDa/CBY co ratio of 0.92 ± 35% for 84 separate regions of interest. Figure 10 illustrates the glucose utilization and blood volume images from a 28-year-old patient with a large arteriovenous malformation in the left precentral area. Figure lOA and B shows low-reso lution CBY images of a cut through the arteriove nous malformation using both C '50 and FDG. Pro files through the two CBY images are compared in Fig. 10D . Small discrepancies are considered to be due mainly to slight slice misalignment and to noise in the FDG blood volume image. Figure 10C shows that the glucose utilization image derived from the measured rate constants is symmetric with no evi dence of reduced LCMR glu in the affected area, while the CBY image shows a large blood pool in that region. This lack of asymmetry in LCMR glu was later confirmed in a separate single-scan FDG study on this patient.
In the present study the mean k3/k2 ratio was 0.74 ± 42.1%, while the corresponding LC stability factor was 1.96 ± 11.2%. Most of this variation is due to intersubject diffe rences. The mean intrasub- ject coefficient of variation is 18.0% for the k3/k2 ratio and 5.0% for the LC stability factor.
DISCUSSION
Recent studies have emphasized the need to de termine in each patient the rate constants for the deoxyglucose model (Hawkins et aI ., 1981 (Hawkins et aI ., , 1983 Friedland et aI ., 1983 ; Weinhard et aI ., 1983 Weinhard et aI ., , 1985 Kato et aI., 1984 ; Heiss et aI ., 1984) . The added information yields a more accurate measurement of regional glucose utilization as well as a better un derstanding of the underlying kinetics. However, the presence of significant activity in the vascular compartment in the early minutes after a bolus in jection of FDG complicates the derivation of accu rate rate constants from the observed tissue uptake curve. To minimize these problems, it is common practice to ignore the first fe w minutes of the tissue curve, where the impact of the vascular component on the data is most pronounced, when fitting only kl-k3 (Heiss et aI ., 1984; Weinhard et aI ., 1985) . Al ternatively, CBY can be measured separately or given some approximate value and the corre sponding activity subtracted before the rate con stant determination.
Direct determination of CBY during the rate con stant analysis removes the possibility of systematic error in the derived rate constants, which can arise from an incorrect assignment of the CBY value . In Fig. 4 the linear distortion in apparent rate con- Mean values and coefficients of variation (COV) (%) for rate constants, CBV, and local CMR gl u (LCMR g [u) in seven older volunteers , with and without explicit CBV determination. LCMR g l U is calculated using Eq. 2 with individual rate constants kl, k2, k3. In all cases k4 was assumed to be 0.0068 min -I. a Data points fitted between 0 and 40 min if CBV determined or between 4 and 40 min if CBV not determined. ROI, region of interest.
stants with increasing CBV is shown. By assuming a CBV fraction of 0.04 and fitting from 2 min on ward, the error in all rate constants is < 10% over the range of 0.02-0.06 in true CBV fractions (Heiss et al ., 1984) . For normal brain tissue this is prob ably acceptable, but significant errors would be ex pected in ischemic or hyperemic pathologies. In pathological states with abnormal vascular compo nents, the direct determination of the CBV fr action obviates the need to perform a separate determina tion of the regional CBY. As a result the attendant problems of image registration can be minimized and the need fo r a second isotope production run and the extra radiation dose can be avoided. Figure 5 demonstrates that omitting the early portion of the tissue curve from analysis increases the uncertainty of the resultant rate constants. As more of the curve is omitted, the results are pro gressively less reliable. The fo ur-parameter fit with CBV explicitly determined exhibits an uncertainty equivalent to that obtained by omitting 2.5-3 min and not determining CBY. This result suggests that the inclusion of the extra parameter provides fu r ther information about the physiological state of the tissue without compromising the accuracy of the rate constant measurement. It also contrasts with the findings of Weinhard et al . (1985) who observed an increase in the number of spurious solutions for the rate constants when the extra blood volume pa rameter was introduced. The apparent anomalous behavior of the 6-min curve at the highest noise levels suggests that in very noisy situations the early scans can introduce more noise than signal and are better ignored. The exact nature of this ap parent improvement is as yet unclear.
The first few minutes of the plasma and tissue curves contribute most of the information about CBV determination, and so it is vital that the shape of the plasma curve be measured accurately. For a rapid bolus injection, a required sampling rate of once every 5 s for the first minute is not unlikely. For manual sampling this may be diffi cult to achieve. If the initial peak in the plasma curve can be broadened, the sampling requirements are re laxed. Figures 7 and 8 show that the root mean square error in the fi tted parameters is lower if the dose is infused over a short period than if adminis tered as a pUlse. Although the parameters show some variation for the optimum infusion period, an infusion over 60 s improves the uncertainty fo r al most all cases. Hence, extending the duration of label injection to � 1 min offers improved accuracy as well as relaxing the sampling constraints. The inclusion of the extra parameter may al so be of use for analyzing the more difficult rapid bolus studies since it can act as a buffer to protect rate constant calculation from the effects of activity in the vascular compartment. Figure 6 shows that errors in the determination of the input fu nction are manifested as a scaling of the apparent CBV while the rate constants are comparatively unaffected. Given that including the extra parameter is no worse than omitting the early phase of the tissue curve in terms of the accuracy of the resultant k values (Fig. 5) , this offers an alternative strategy for performing blood volume correction even though the correct CBV value might not be obtained.
Since the times for the injected bolus to reach the head and the plasma-sampling site are generally not the same, there is an inherent uncertainty in rela tive timing of the plasma and tissue curves. If the entire tissue time course is to be used in the anal- Vol. 6, No.6, /986 ysis, then the effects of time mismatches between plasma and tissue curves must be considered. Raichle et al . (1983) have observed that the tissue curye precedes the plasma curve , sampled at the radial artery, by 5-10 s. Figure 9 shows that unless this difference is removed by a suitable time shift , CBV will be oyerestimated and the rate constants will be underestimated . Assuming a 9-s delay and a CBV fraction of 0.04, the largest rate constant error is in k2 and is <9% for the 60-s infusion. At a CBV fraction of 0. 10, this error rises to 16%. Apparent CBV yalues exceed their true values by 25 -40% if a 9-s delay is not removed. Interestingly, the ex tended infusion method is more susceptible to timing errors than the rapid bolus approach. This behavior was also observed for bolus H2150 blood flow studies by Herscovitch et al . (1983) . It appears that in the bolus approach the deleterious effects of the mismatch are confined to fe wer tissue samples and can be overcome by the fi tting algorithm, which tends to ignore obvious outlying points. For the extended infusion the vascular contribution is considerable fo r two or three tissue samples and has a stronger influence on the re sulting fi t. Hawkins et al . (1986) have shown similar simula tions and have concluded that longer scan dura tions are less susceptible to timing errors than are the 30-s scans shown in Fig. 9 .
The rate constant values obtained from the seven subjects (Table 2) As tabulated, the two columns illustrate the com bined impact of these two systematic errors . Using a two-tailed t test for comparison of inde pendent means, the kl value in the occipital cortex (0. 095 min-I ) was significantly higher than the average value in all other regions of 0.082 min -I (t = 3.89, p < 0.001), while in the anterior/midfrontal region, the kl value of 0.076 min -I was significantly lower (t = 2.63, p < 0.01). No other significant dif fe rences among regions were fo und for kl' k2' or k3. The anterior region also showed a reduction in CBV fraction of 0.030 compared with the average value in all other regions of 0.042 (t = 3.02, p < 0.01). If the coefficient-of-variation values for the observed rate constants and CBV fraction are compared with the simulated data from Fig . 5 , it is apparent that much of the variability observed can be attributed to the uncertainty in the fitting procedure . Al though Fig. 5 refers to a rapid bolus injection, sim ilar behavior is observed for the 60-s infusion case. For example , at a mean noise level of 4%, the ex pected root mean square error for kl is 13%, fo r k2 35%, for k3 21%, and for CBV 30%. Corresponding coefficients of variation for the four parameters in all gray structures are 15, 47 , 45 , and 36%, respec tively. It appears that kl and CBV are maintained within a relatively narrow range . Much of the in creased coefficient of variation fo und for k2 and k3 No, 6, 1986 is due to the anterior/midfrontal data, which exhibit coefficients of variation over 70% for these param eters . The increased variability of these two param eters over that expected from noise considerations alone might suggest a compensatory mechanism whereby backflow (k2) is reduced to compensate fo r a reduction in phosphorylation capacity (k3) ' Al ternatively, other methodological fac tors such as timing variations between brain and plasma curves could cause coupled changes in k2 and k3• One subject (FO) exhibited a mean k2 value (0. 079 min -I) that was significantly different (t = 4.42, p < 0.001) from the mean gray matter k2 in all other patients of 0.161 ± 42.1%. Excluding patient FO caused minimal changes in kl' k3' and CBV fraction.
In comparing the rate constants for older volun teers from this work with those from other studies (Table 4) , the question of partial volume must be considered (Hoffman et aI ., 1979; Mazziotta et aI ., 1981) . The value of kl' which is linearly dependent upon the magnitude of the tissue curve , is most likely to be affected by the size and shape of the region of interest and the resolution. Ta ble 4 shows that the mean gray matter value for kl of 0.084 min -I is somewhat lower than those from compa rable studies from other centers . This may be a re sult of the lower resolution of the dynamic data in this work, although the lack of a common strategy for region-of-interest specification renders direct comparison difficult. On the other hand, when the CBV term is omitted, the kl value increases to 0.091 min -I, in good agreement with these other studies.
The changes in the rate constants when CBV is included in the fit, described in Tables 2 and 3, ex hibit the behavior expected from Figs. 4 and 5 for both mean value and coefficient of variation. In the simulation the apparent values for kl and k2 were elevated and for k3 were depressed relative to their true values if CBV was not explicitly fi tted. This suggests that the values obtained in the present study with CBV fi tted are the more correct esti mates. Although these differences are relatively small in normal tissue, larger distortions would be expected in hyperemic tissue.
The mean value for cortical CBV fraction from this older control group was 0.040 ± 35%. Phelps et al . (1979b) reported a whole-brain average CBV of 4.2 ± 10% ml/100 g using IIC-Iabeled CO in five young volunteers , while other studie s indicated cortical values of 5-6 ml/100 g (Phelps et aI ., 1973 ; Ladurner et aI ., 1976) . The lower value obtained in this study probably reflects the lower resolution of the dynamic FDG scans, giving rise to gray/white averaging, more than the presence of age-related differences. The quality of the CBV image obtained from the analysis of FDG dynamic curves is poorer than that obtained using specific CBV indicators such as carbon monoxide. The ratio for CBV FDGI CBV c o of 0.92 ± 35% over 84 regions of interest in six subjects suggests no systematic difference be tween the two methods. Hawkins et al . (1986) ob tained a CBV ratio of 0.79 ± 78% in fo ur tumor patients. These two comparisons indicate that while the ratios are not significantly different from unity, methodological errors and physiological vari ability introduce large coefficients of variation that make direct confirmation of the FDG values with C150 values difficult. However, as shown in Fig . 10 fo r an arteriovenous malformation case where large variations in regional CBV are present, the method does produce maps that contain the correct vas cular distribution and that agree with the quantita tive measurements fr om the direct approach. While the kinetics of FDG in an arteriovenous malforma tion is not of particular interest, this example dem onstrates the dynamic range of the CBV determina tion and indicates that the method is applicable for hyperemic pathologies where glucose metabolism is of interest. The overall LC stability factor of 1.96 ± 11.2% may be compared with the value of 1.68 ± 20.8% from Phelps et al . (1983) and 1.81 ± 11.9% calcu lated from the rate constant data of Huang et al . (1980) . The fo rm of Eq. 11 is such that the large variations in the k/k2 ratio among regions observed in this study are considerably reduced for the sta bility factor, as would be expected if the lumped constant is indeed constant. The small mean intra-subject coefficient of variation of 5.0% for the LC stability fa ctor despite large variations in the k31k2 ratio supports the contention that the lumped con stant is regionally invariant under normal condi tions. The increased value in the LC stability fa ctor for the present study as compared with that of Phelps et al . (1983) reflects the increased k3 value observed fo r the older control group.
CONCLUSION
The results obtained indicate that it is possible to determine simultaneously the regional distribution for the FDG rate constants and blood volume in the brain using PET. The uncertainty in the measured rate constants is comparable with that obtained when the effects of vascular activity are diminished by the omission of the first few minutes of tissue data during analysis.
